Angel Biotechnology expects to complete Materia Medica jv by end of 2012 – Proactive Investors UK
By Dr. Matthew Watson
 Proactive Investors UK | Angel Biotechnology expects to complete Materia Medica jv by end of 2012 Proactive Investors UK Biopharmaceutical contract manufacturer Angel Biotechnology (LON:ABH) expects its joint venture with Russian firm Materia Medica to be completed before the end of the year. The firm is still dealing with the details of the agreement, it said in a wide ... |
Source:
http://news.google.com/news?q=biotechnology&output=rss
Uncategorized
Comments Off on Angel Biotechnology expects to complete Materia Medica jv by end of 2012 – Proactive Investors UK |
September 16th, 2012
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research